Churg-Strauss syndrome: Clinical symptoms, complementary investigations, prognosis and outcome, and treatment

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 3, 2011, Pages 298-309

  Dunogué, Bertrand ^a,b   Pagnoux, Christian ^a,b   Guillevin, Loïc ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

ANCA; Churg Strauss syndrome; immunosuppressants; steroids; vasculitis

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; EOTAXIN 3; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MEPOLIZUMAB; METHOTREXATE; METHYLPREDNISOLONE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; OMALIZUMAB; PREDNISONE; RITUXIMAB; VITAMIN D;

ABDOMINAL PAIN; ANCA ASSOCIATED VASCULITIS; ANGIOGRAPHY; ARTICLE; ASTHMA; BLOOD VESSEL PARAMETERS; BRONCHOSPASM; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL ADHESION; CHURG STRAUSS SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FIVE FACTOR SCORE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; HYPEREOSINOPHILIA; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INTESTINAL BLEEDING; INTESTINE PERFORATION; LOW DRUG DOSE; MAINTENANCE THERAPY; MORBIDITY; MYALGIA; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PNEUMOCYSTIS JIROVECI; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PURPURA; REGULATORY T LYMPHOCYTE; RISK FACTOR; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC VASCULITIS; TH1 CELL; TH2 CELL; TREATMENT DURATION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADRENAL CORTEX HORMONES; ASTHMA; AZATHIOPRINE; CHURG-STRAUSS SYNDROME; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; PHYSICAL THERAPY MODALITIES; PLASMA EXCHANGE; PREVALENCE; PROGNOSIS; TREATMENT OUTCOME;

EID: 79959235189     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1279826     Document Type: Article

References (93)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951 27 2 277-301
2. Masi A T., Hunder G G., Lie J T. et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990 33 8 1094-1100 (Pubitemid 20273293)
3. Jennette J C., Falk R J., Andrassy K et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994 37 2 187-192 (Pubitemid 24065492)
4. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999 78 1 26-37 (Pubitemid 29065978)
5. Sablé-Fourtassou R, Cohen P, Mahr A et al, French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005 143 9 632-638 (Pubitemid 41552527)
6. Sinico R A., Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005 52 9 2926-2935 (Pubitemid 41369124)
7. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011 90 1 19-27
8. Lanham J G., Elkon K B., Pusey C D., Hughes G R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984 63 2 65-81 (Pubitemid 14166819)
9. Guillevin L, Amouroux J, Arbeille B, Boura R. Churg-Strauss angiitis: arguments favoring the responsibility of inhaled antigens. Chest 1991 100 5 1472-1473
10. Manger B J., Krapf F E., Gramatzki M et al. IgE-containing circulating immune complexes in Churg-Strauss vasculitis. Scand J Immunol 1985 21 4 369-373 (Pubitemid 15233209)
11. Bottero P, Bonini M, Vecchio F et al. The common allergens in the Churg-Strauss syndrome. Allergy 2007 62 11 1288-1294 (Pubitemid 47537511)
12. Falk R J., Terrell R S., Charles L A., Jennette J C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990 87 11 4115-4119 (Pubitemid 20217992)
13. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002 110 7 955-963
14. Heeringa P, Brouwer E, Tervaert J W., Weening J J., Kallenberg C G. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 1998 53 2 253-263 (Pubitemid 28097840)
15. Tsukadaira A, Okubo Y, Kitano K et al. Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 1999 20 1 39-44
16. Tai P C., Holt M E., Denny P, Gibbs A R., Williams B D., Spry C J. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) 1984 289 6442 400-402 (Pubitemid 14010301)
17. Schmitt W H., Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross W L. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998 41 3 445-452 (Pubitemid 28128769)
18. Peen E, Hahn P, Lauwers G, Williams R C. Jr, Gleich G, Kephart G M. Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 2000 43 8 1897-1900
19. Cottin V, Tardy F, Gindre D, Vernet G, Deviller P, Cordier J F. Urinary eosinophil-derived neurotoxin in Churg-Strauss syndrome. J Allergy Clin Immunol 1995 96 2 261-264
20. Higashi N, Mita H, Taniguchi M et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol 2004 114 6 1353-1358 (Pubitemid 39575889)
21. Kiene M, Csernok E, Mller A, Metzler C, Trabandt A, Gross W L. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001 44 2 469-473
22. Taki H, Shinoda K, Hounoki H et al. Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid. Scand J Rheumatol 2010 39 4 341-343
23. Termeer C, Simon J C., Schöpf E. Churg-Strauss syndrome associated with fluticasone therapy. Arch Dermatol 2001 137 11 1527-1528 (Pubitemid 33064255)
24. Terrier B, Biche I, Maisonobe T et al. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood 2010 116 22 4523-4531
25. Mschen M, Warskulat U, Perniok A et al. Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol 1999 155 3 915-925 (Pubitemid 29426838)
26. Polzer K, Karonitsch T, Neumann T et al. Eotaxin-3 is involved in Churg-Strauss syndromea serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008 47 6 804-808 (Pubitemid 351796364)
27. Hellmich B, Csernok E, Gross W L. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann N Y Acad Sci 2005 1051 121-131 (Pubitemid 41362739)
28. Pagnoux C. Churg-Strauss syndrome: evolving concepts. Discov Med 2010 9 46 243-252
29. Saito H, Tsurikisawa N, Tsuburai T, Akiyama K. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome. Int Arch Allergy Immunol 2008 146 suppl 1 73-76
30. Saito H, Tsurikisawa N, Tsuburai T, Oshikata C, Akiyama K. Cytokine production profile of CD4+T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009 149 suppl 1 61-65
31. Wieczorek S, Holle J U., Bremer J P. et al. Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome. Rheumatology (Oxford) 2010 49 5 907-914
32. Wieczorek S, Holle J U., Epplen J T. Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol 2010 22 1 8-14
33. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004 51 1 92-99 (Pubitemid 38222288)
34. Haugeberg G, Bie R, Bendvold A, Larsen A S., Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 1998 17 5 364-368 (Pubitemid 28483133)
35. Martin R M., Wilton L V., Mann R D. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999 8 3 179-189 (Pubitemid 29286530)
36. Watts R A., Lane S E., Bentham G, Scott D G. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000 43 2 414-419 (Pubitemid 30395752)
37. Watts R A., Lane S, Scott D G. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005 19 2 191-207
38. Harrold L R., Andrade S E., Go A S. et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005 32 6 1076-1080 (Pubitemid 40828082)
39. Dietz A, Hbner C, Andrassy K. Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome) [in German]. Laryngorhinootologie 1998 77 2 111-114
40. Imai H, Nakamoto Y, Hirokawa M, Akihama T, Miura A B. Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure. Nephron 1989 51 3 405-408 (Pubitemid 19056736)
41. Mathur S, Dooley J, Scheuer P J. Quinine induced granulomatous hepatitis and vasculitis. BMJ 1990 300 6724 613 (Pubitemid 20090311)
42. Guillevin L, Guittard T, Blétry O, Godeau P, Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung 1987 165 3 165-172 (Pubitemid 17083613)
43. Green R L., Vayonis A G. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 1999 353 9154 725-726 (Pubitemid 29103814)
44. Franco J, Artés M J. Pulmonary eosinophilia associated with montelukast. Thorax 1999 54 6 558-560 (Pubitemid 29241632)
45. Wechsler M E., Drazen J M. Zafirlukast and Churg-Strauss syndrome. Chest 1999 116 1 266-267
46. Wechsler M E., Finn D, Gunawardena D et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000 117 3 708-713 (Pubitemid 30152209)
47. Wechsler M E., Wong D A., Miller M K., Lawrence-Miyasaki L. Churg-Strauss syndrome in patients treated with omalizumab. Chest 2009 136 2 507-518
48. Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J. Administration of anti-IgE to a Churg-Strauss syndrome patient. Int Arch Allergy Immunol 2007 144 2 155-158 (Pubitemid 47414331)
49. Puéchal X, Rivereau P, Vinchon F. Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med 2008 19 5 364-366 (Pubitemid 351783388)
50. Hauser T, Mahr A, Metzler C et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 2008 63 8 677-682
51. Wechsler M E., Pauwels R, Drazen J M. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal? Drug Saf 1999 21 4 241-251
52. Chumbley L C., Harrison E G. Jr, DeRemee R A. Allergic granulomatosis and angiitis (Churg-Strauss syndrome): report and analysis of 30 cases. Mayo Clin Proc 1977 52 8 477-484 (Pubitemid 8161397)
53. Gaskin G, Clutterbuck E J., Pusey C D. Renal disease in the Churg-Strauss syndrome: diagnosis, management and outcome. Contrib Nephrol 1991 94 58-65
54. Haas C, Geneau C, Odinot J M. et al. Angéïte allergique et granulomateuse: le syndrome de ChurgStrauss: Étude rétrospective de 16 cas. Ann Med Interne (Paris) 1991 142 5 335-342
55. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome: an analysis of twenty-five patients. Arthritis Rheum 1994 37 12 1798-1803 (Pubitemid 24371883)
56. Riva N, Cerri F, Butera C et al. Churg Strauss syndrome presenting as acute neuropathy resembling Guillain Barré syndrome: case report. J Neurol 2008 255 11 1843-1844
57. Guillevin L, Lhote F, Gayraud M et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996 75 1 17-28 (Pubitemid 26041085)
58. Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005 84 2 115-128 (Pubitemid 40418640)
59. Cottin V, Cordier J F. Eosinophilic pneumonias. Allergy 2005 60 7 841-857 (Pubitemid 40813804)
60. Bhagirath K M., Paulson K, Ahmadie R, Bhalla R S., Robinson D, Jassal D S. Clinical utility of cardiac magnetic resonance imaging in Churg-Strauss syndrome: case report and review of the literature. Rheumatol Int 2009 29 4 445-449
61. Marmursztejn J, Cohen P, Duboc D et al. Cardiac magnetic resonance imaging in Churg-Strauss-syndrome: impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin Exp Rheumatol 2010 28 1, suppl 57 8-13
62. Marmursztejn J, Vignaux O, Cohen P et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 2009 27 1, suppl 52 S70-S76
63. Androudi S, Iaccheri B, Brazitikos P, Papadaki T, Foster C S. Bilateral chronic anterior uveitis & neuro-ophthalmologic manifestations in a patient with Churg-Strauss syndrome: an unusual ocular presentation. Ocul Immunol Inflamm 2004 12 1 59-63 (Pubitemid 38406454)
64. Fernandez A J. Ureteral granuloma in Churg-Strauss syndrome. Mayo Clin Proc 1978 53 9 618
65. Modigliani R, Muschart J M., Galian A, Clauvel J P., Piel-Desruisseaux J L. Allergic granulomatous vasculitis (Churg-Strauss Syndrome): report of a case with widespread digestive involvement. Dig Dis Sci 1981 26 3 264-270 (Pubitemid 11147022)
66. Généreau T, Lortholary O, Pottier M A. et al, French Vasculitis Study Group. Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. Arthritis Rheum 1999 42 12 2674-2681 (Pubitemid 30327190)
67. Lie J T., Bayardo R J. Isolated eosinophilic coronary arteritis and eosinophilic myocarditis: a limited form of Churg-Strauss syndrome. Arch Pathol Lab Med 1989 113 2 199-201 (Pubitemid 19053728)
68. Lie J T. Limited forms of Churg-Strauss syndrome. Pathol Annu 1993 28 Pt 2 199-220
69. Steinfeld S, Golstein M, De Vuyst P. Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg-Strauss syndrome (CSS). Eur Respir J 1994 7 11 2098 (Pubitemid 24366310)
70. Terrier B, Saadoun D, Sene D et al. Anti-myeloperoxidase antibodies are a useful marker of disease activity in ANCA-associated vasculitides. Ann Rheum Dis 2008 68 1564-1578
71. Wallaert B, Gosset P, Prin L, Bart F, Marquette C H., Tonnel A B. Bronchoalveolar lavage in allergic granulomatosis and angiitis. Eur Respir J 1993 6 3 413-417 (Pubitemid 23114890)
72. Finan M C., Winkelmann R K. The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Baltimore) 1983 62 3 142-158 (Pubitemid 13096628)
73. Reid A J., Harrison B D., Watts R A., Watkin S W., McCann B G., Scott D G. Churg-Strauss syndrome in a district hospital. QJM 1998 91 3 219-229 (Pubitemid 28115855)
74. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003 54 169-184 (Pubitemid 37386390)
75. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951 27 2 277-301
76. Hoffman G S., Kerr G S., Leavitt R Y. et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992 116 6 488-498
77. Cohen P, Pagnoux C, Mahr A et al, French Vasculitis Study Group. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 2007 57 4 686-693 (Pubitemid 46764061)
78. Bourgarit A, Le Toumelin P, Pagnoux C et al, French Vasculitis Study Group. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005 84 5 323-330 (Pubitemid 41368485)
79. Ribi C, Cohen P, Pagnoux C et al, French Vasculitis Study Group. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 2008 58 2 586-594 (Pubitemid 351294896)
80. Guillevin L. Clinical trials on systemic necrotizing vasculitides. Presse Med 2010 39 6 653-659
81. Gayraud M, Guillevin L, Cohen P et al, French Cooperative Study Group for Vasculitides. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol 1997 36 12 1290-1297
82. Metzler C, Hellmich B, Gause A, Gross W L., de Groot K. Churg Strauss syndromesuccessful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol 2004 22 6, suppl 36 S52-S61
83. Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010 22 1 21-28
84. Koukoulaki M, Smith K G., Jayne D R. Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 2006 65 4 557-559
85. Pepper R J., Fabre M A., Pavesio C et al. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford) 2008 47 7 1104-1105 (Pubitemid 351865947)
86. Bouldouyre M A., Cohen P, Guillevin L. Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome. Ann Rheum Dis 2009 68 4 606
87. Metzler C, Schnabel A, Gross W L., Hellmich B. A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin Exp Rheumatol 2008 26 3, suppl 49 S35-S40
88. Giavina-Bianchi P, Agondi R, Kalil J. One year administration of anti-IgE to a patient with Churg-Strauss syndrome. Int Arch Allergy Immunol 2008 146 2 176 (Pubitemid 351685483)
89. Hamilos D L., Christensen J. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. J Allergy Clin Immunol 1991 88 5 823-824
90. Rutberg S A., Ward D E., Roth B J. Churg-Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin. J Clin Rheumatol 2002 8 3 151-156 (Pubitemid 34680721)
91. Taniguchi M, Tsurikisawa N, Higashi N et al. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol Int 2007 56 2 97-103 (Pubitemid 46984237)
92. Jayne D R., Gaskin G, Rasmussen N et al, European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007 18 7 2180-2188 (Pubitemid 47041083)
93. Jayne D R., Gaskin G, Rasmussen N et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007 18 7 2180-2188 (Pubitemid 47041083)